Survival outcomes for extranodal natural-killer T-cell lymphoma - Authors' reply
Lancet Haematol
.
2020 Jun;7(6):e442.
doi: 10.1016/S2352-3026(20)30152-6.
Authors
Christopher P Fox
1
,
Monica Civallero
2
,
Massimo Federico
2
,
Won S Kim
3
Affiliations
1
Department of Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
2
CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.
3
Division of Hematology-Oncology, Samsung Medical Center, Seoul 06351, Korea. Electronic address: wskimsmc@skku.edu.
PMID:
32470432
DOI:
10.1016/S2352-3026(20)30152-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Lymphoma, Extranodal NK-T-Cell*